Pharmafile Logo

rPPG

- PMLiVE

COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP

Pfizer’s oral antiviral was granted accelerated approval in the US in December 2021

- PMLiVE

BMS and Janssen’s antithrombotic granted FDA fast track designation

The three indications include ischaemic stroke, acute coronary syndrome and atrial fibrillation

Patient Clinical Trial & Communications Plan Review: A Customer Story

Our client reached out to Impetus to help establish a virtual patient panel with the aim to gather insights on their unmet needs, the most important attributes of treatment, and the impact of...

Impetus Digital

- PMLiVE

Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023

During the 2023 annual meeting of ACOG, Medscape highlighted the outcomes of CME/CE programs focused on improving clinicians knowledge and achieving better outcomes for patients. The outcomes were shared through...

Medscape Education

- PMLiVE

FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis

Ayvakit is now the first and only approved medicine designed to treat the underlying cause of the disease

- PMLiVE

Decision date for Sarepta’s Duchenne muscular dystrophy gene therapy delayed by FDA

The disease occurs in up to one in every 5,000 newborn males worldwide

- PMLiVE

Almirall and CRG announce non-melanoma skin cancer research collaboration

The partners will jointly develop novel preclinical models to identify new treatments for NMSC

- PMLiVE

Seqera Labs and Genomics England partner to progress genomic research

The collaboration is aimed at helping more patients benefit from genomic healthcare

- PMLiVE

Medscape Collaborates for Health Equity at DDW 2023

Recently, DDW 2023 took place in Chicago, IL, and Medscape was on-site with patient advocacy organizations to help educate clinicians on health equity in gastroenterology.Medscape was joined during the conference...

Medscape Education

- PMLiVE

Sanofi/Regeneron’s Dupixent shows promise in chronic obstructive pulmonary disease

Approximately 300,000 people in the US live with uncontrolled COPD with evidence of type 2 inflammation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links